Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

AHK-Cu and Tesamorelin Interaction: Synergistic | Peptide Database

Compound Profiles AHK-Cu Hair Growth Copper Peptide | Dermal Papilla Stimulator AHK-Cu penetrates scalp delivering copper directly to dermal papilla cells. Activates proliferation pathways, elevates Bcl-2/Bax ratio (anti-apoptotic), increases VEGF for blood fl

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

AHK-Cu

Hair Growth Copper Peptide | Dermal Papilla Stimulator

AHK-Cu penetrates scalp delivering copper directly to dermal papilla cells. Activates proliferation pathways, elevates Bcl-2/Bax ratio (anti-apoptotic), increases VEGF for blood flow, reduces TGF-β1, and promotes SOD production for oxidative stress reduction.

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Combined Organ Load

Frequently Asked Questions

Can I take AHK-Cu with Tesamorelin?

Yes, AHK-Cu and Tesamorelin can generally be taken together. AHK-Cu and Tesamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is AHK-Cu and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between AHK-Cu and Tesamorelin?

AHK-Cu and Tesamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time AHK-Cu and Tesamorelin?

AHK-Cu has a half-life of Not established and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Primary mechanism activating dormant muscle satellite cells which fuse to damaged fibers. Increases proliferative lifespan in younger muscle progenitor cells. Increases activated satellite cell fusion capacity supporting repair and hypertrophy. Animal studies suggest improved Achilles tendon injury outcomes. Rabbit models demonstrated faster healing via osteoblast regulation. Research indicates potential for articular cartilage injury models. Naturally upregulated after mechanical stress; supplementation may enhance processes. Localized injection near injury sites supports targeted tissue repair.

Source: peptide-db.com ↗

Research Indications

Age-related decline in thymulin correlates with reduced immune function; supplementation may restore T-cell parameters. Promotes differentiation and maturation of T-lymphocytes in thymus. Thymulin activity depends on zinc; studied in zinc-depleted conditions. Research shows thymulin suppresses pro-inflammatory cytokines and mediators. Investigated for potential to restore immune balance in autoimmune states. Studied for effects on pancreatic beta cells and immune modulation in diabetes models. Thymulin influences hypothalamic-pituitary-adrenal axis function. Some research suggests protective effects on neural tissue.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Subcutaneous injection is the primary administration route studied in preclinical research. Human pharmacokinetic data is very limited. Cognitive support (research protocol) 100-200mcg 1x daily SubQ

Source: peptide-db.com ↗
Side effects

Common Side Effects

Mild gastrointestinal discomfort (nausea, dyspepsia, or stomach upset -- typically transient and dose-dependent) Occasional heartburn or acid reflux, especially at higher doses or when taken on an empty stomach

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides